The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide ID: ALA379553
Cas Number: 171628-57-2
PubChem CID: 748028
Max Phase: Preclinical
Molecular Formula: C20H15N3O
Molecular Weight: 313.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1c(-c2ccccc2)nc2ccccn12)c1ccccc1
Standard InChI: InChI=1S/C20H15N3O/c24-20(16-11-5-2-6-12-16)22-19-18(15-9-3-1-4-10-15)21-17-13-7-8-14-23(17)19/h1-14H,(H,22,24)
Standard InChI Key: MFEAOWRPVOQOEV-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
15.3913 -14.2776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5631 -15.0873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3488 -15.3418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9633 -14.7877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7869 -13.9756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0015 -13.7249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6036 -14.0255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4309 -13.2182 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9908 -14.5785 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2054 -14.3244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8716 -14.3236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.5401 -14.8078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5404 -15.6316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8242 -16.0442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8244 -16.8688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5401 -17.2820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2570 -16.8643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2533 -16.0410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1257 -13.5382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9500 -13.5379 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3601 -12.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9471 -12.1121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1197 -12.1163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7132 -12.8296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19 11 2 0
11 12 1 0
12 10 2 0
6 1 2 0
1 2 1 0
13 14 2 0
3 4 1 0
14 15 1 0
15 16 2 0
7 8 2 0
16 17 1 0
7 9 1 0
17 18 2 0
18 13 1 0
12 13 1 0
1 7 1 0
4 5 2 0
19 20 1 0
9 10 1 0
20 21 1 0
10 20 1 0
21 22 2 0
2 3 2 0
22 23 1 0
5 6 1 0
23 24 2 0
24 19 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 313.36Molecular Weight (Monoisotopic): 313.1215AlogP: 4.25#Rotatable Bonds: 3Polar Surface Area: 46.40Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.51CX LogP: 3.97CX LogD: 3.97Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.61Np Likeness Score: -1.82
References 1. de Paulis T, Hemstapat K, Chen Y, Zhang Y, Saleh S, Alagille D, Baldwin RM, Tamagnan GD, Conn PJ.. (2006) Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes., 49 (11): [PMID:16722652 ] [10.1021/jm051252j ] 2. PubChem BioAssay data set, 3. Rostrup F, Falk-Petersen CB, Harpso E K, Buchleithner S, Conforti I, Jung S, Gloriam DE, Schirmeister T, Wellendorph P, Fro Lund B.. (2021) Structural Determinants for the Mode of Action of Imidazopyridine DS2 at δ-Containing γ-Aminobutyric Acid Type A Receptors., 64 (8.0): [PMID:33847501 ] [10.1021/acs.jmedchem.0c02163 ]